Previous 10 | Next 10 |
home / stock / acb / acb articles
Aurora Cannabis Inc (NASDAQ:ACB) shares are in the spotlight Tuesday. The company’s previously announced share consolidation is set to go int...
In a revealing interview on Benzinga's Cannabis Insider podcast, Miguel Martin, CEO of Aurora Cannabis Inc (NASDAQ:ACB), offered an in-depth l...
Canadian medical cannabis giant Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB) reported its financial and operational results on Thursday for the thir...
Even though the European cannabis scene has not yet witnessed unexpected large-scale shifts, markets like the U.K., Germany, Denmark, Portugal and ...
On Tuesday cannabis stocks and ETFs started the trading day on a positive note following the release of documents related to the Department of Heal...
Zuanic & Associates has initiated coverage on Village Farms International (NASDAQ: VFF), assigning an "Overweight" rating. What are t...
Serious research is picking up on the potential mental health benefits of coca plant. Despite its historical stigma related to its a...
Five years into its legalization, the Canadian cannabis market reveals intriguing regional disparities and growth trends, as highlighted in the lat...
Irwin Simon, a chairman and CEO of the largest Canadian cannabis company in the world, Tilray Brands (NASDAQ: TLRY), recently took a business and p...
News, Short Squeeze, Breakout and More Instantly...
--News Direct-- When it comes to investing in the legal marijuana industry, they don't call it the "green rush" for nothing. Many analysts are projecting massive growth for the cannabis industry. New Frontier, a Washington D.C.-based cannabis research firm, expects total U.S. legal cannabis s...
2024-07-18 05:30:00 ET To say Aurora Cannabis (NASDAQ: ACB) has faced some challenges over the years would be a huge understatement. The once-leading cannabis producer in the Canadian marijuana industry is now a shell of its former self. Instead of acquiring large cannabis compani...
The marijuana industry has been significantly hindered by Section 280E of the IRS Code , which prevents businesses dealing with substances listed in Schedules 1 and 2 of the Controlled Substances Act (CSA) from deducting regular business expenses. Although Section 280E affects federal deductio...